XPhyto Therapeutics (CSE: XPHY- OTCQB: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive with news the company has received the first purchases of their 25 minute rapid PCR test which is being manufactured in Germany.
These tests will be used for regulatory approvals in a number of different markets. Rogers telling Proactive who big that order is and also that they have hired a very experienced sales team to take the lead on getting those test kits out to market.